Dr. Daifuku is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9270 Se 36th Pl
Mercer Island, WA 98040Phone+1 206-232-0061
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1987 - 1990
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1985 - 1987
University of Washington School of MedicineClass of 1983
Publications & Presentations
PubMed
- 3 citationsNUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2',2'-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung CancerRichard Daifuku, Sheila D. Grimes, Murray Stackhouse
Pharmaceuticals. 2018-04-23 - 7 citationsVitamin E Phosphate Nucleoside Prodrugs: A Platform for Intracellular Delivery of Monophosphorylated NucleosidesRichard Daifuku, Michael S. Koratich, Murray Stackhouse
Pharmaceuticals. 2018-02-06 - 3 citations5-aza-2',2'-Difluoro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer.Richard Daifuku, Zhenbo Hu, Yogen Saunthararajah
Pharmaceuticals. 2017-07-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
